Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein (Q24292317)

GOA release 2020-03-11

1 reference

2

Heather Snyder

0 references

author name string

Natalie Golts

1

0 references

Mark Frasier

3

0 references

Catherine Theisler

4

0 references

Peter Choi

5

0 references

Benjamin Wolozin

Journal of Biological Chemistry

6

0 references

language of work or name

English

0 references

publication date

3 May 2002

0 references

published in

0 references

volume

277

0 references

issue

18

0 references

page(s)

16116-23

0 references

cites work

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Neuropathology of synuclein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

A transmembrane form of the prion protein in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

The cellular prion protein binds copper in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Iron and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Strain-specific prion-protein conformation determined by metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Parkinsonism: onset, progression, and mortality. 1967

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Sequestration of iron by Lewy bodies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Tyrosinate fluorescence maxima at 345 nm in proteins lacking tryptophan at pH 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

B lymphocytes and neuroinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

7 January 2021

The cellular prion protein binds copper in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

7 January 2021

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

7 January 2021

Neuropathology in mice expressing human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

7 January 2021

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

7 January 2021

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107866200

7 January 2021

Identifiers

DOI

10.1074/JBC.M107866200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11850416

1 reference

Consolidated OpenCitations Corpus – April 2017